Botox
Real, noticeable results with BOTOX Cosmetic (onabotulinumtoxinA)

Moderate to severe glabellar lines



Actual patient. Results may vary. Photos taken at maximum frown before treatment with BOTOX Cosmetic (onabotulinumtoxinA) and taken at maximum frown after treatment with BOTOX Cosmetic at day 7 and months 3 and 4.

In clinical trials at day 7, 74% (299/405) of patients demonstrated none or mild glabellar line severity at maximum frown as compared to 6% (8/132) in placebo, as assessed by investigators; at day 30, 80% (325/405) of patients demonstrated the same as compared to 3% (4/403) of patients demonstrated the same as compared to 2% (2/128) in placebo; at month 4, 25% (102/403) of patients demonstrated the same as compared to 2% (2/128) in placebo.

In clinical trials at day 7, 82% (334/405) of patients achieved at least a moderate improvement in their glabellar line appearnce compared to 9% (12/132) in placebo, as evaluated by patients; at day 30, 89% (362/405) of patients assessed the same as compared to 7% (9/132) in placebo; at month 3, 63% (254/403) of patients assessed the same as compared to 3% (4/128) in placebo; at month 4, 39% (157/403) of patients assessed the same as compared to 1% (1/128) in placebo.

Moderate to severe crow's feet